- Stocks
- Healthcare
- NASDAQ: QDEL

Price (delayed)

$87.57

Market cap

$5.82B

P/E Ratio

9.07

Dividend/share

N/A

EPS

$9.66

Enterprise value

$8.36B

Quidel Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide. On May 8, 2020 the U.S. Food and Drug Administration has issued the first emergency

The equity has soared by 156% YoY and by 2.9% from the previous quarter

QDEL's revenue has surged by 92% year-on-year and by 8% since the previous quarter

The stock's price to earnings (P/E) is 75% less than its 5-year quarterly average of 35.7 but 65% more than its last 4 quarters average of 5.4

Quidel's gross profit has surged by 51% YoY but it has decreased by 2% QoQ

QDEL's quick ratio has plunged by 79% YoY

The company's EPS fell by 49% QoQ and by 42% YoY

What are the main financial stats of QDEL

Market
Valuations
Earnings

Shares outstanding

66.51M

Market cap

$5.82B

Enterprise value

$8.36B

Price to earnings (P/E)

9.07

Price to book (P/B)

1.17

Price to sales (P/S)

1.52

EV/EBIT

10.3

EV/EBITDA

7.63

EV/Sales

2.56

Revenue

$3.27B

EBIT

$811.6M

EBITDA

$1.1B

Free cash flow

$762.8M

Per share
Balance sheet
Liquidity

EPS

$9.66

Free cash flow per share

$13.43

Book value per share

$74.72

Revenue per share

$57.5

TBVPS

$57.31

Total assets

$8.86B

Total liabilities

$3.92B

Debt

$2.82B

Equity

$4.93B

Working capital

$568.1M

Debt to equity

0.57

Current ratio

1.56

Quick ratio

0.79

Net debt/EBITDA

2.31

Margins
Efficiency
Dividend

EBITDA margin

33.5%

Gross margin

59.3%

Net margin

16.8%

Operating margin

25.8%

Return on assets

7.5%

Return on equity

12.9%

Return on invested capital

21.2%

Return on capital employed

10.3%

Return on sales

24.8%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Quidel stock price performed over time

Intraday

1.94%

1 week

3.28%

1 month

-2.51%

1 year

-23.26%

YTD

2.22%

QTD

2.22%

How have Quidel's revenue and profit performed over time

Revenue

$3.27B

Gross profit

$1.94B

Operating income

$843.7M

Net income

$548.7M

Gross margin

59.3%

Net margin

16.8%

QDEL's revenue has surged by 92% year-on-year and by 8% since the previous quarter

QDEL's net margin has plunged by 60% YoY and by 37% from the previous quarter

Quidel's operating margin has plunged by 52% YoY and by 31% from the previous quarter

Quidel's gross profit has surged by 51% YoY but it has decreased by 2% QoQ

What is Quidel's growth rate over time

What is Quidel stock price valuation

P/E

9.07

P/B

1.17

P/S

1.52

EV/EBIT

10.3

EV/EBITDA

7.63

EV/Sales

2.56

The stock's price to earnings (P/E) is 75% less than its 5-year quarterly average of 35.7 but 65% more than its last 4 quarters average of 5.4

The company's EPS fell by 49% QoQ and by 42% YoY

The equity has soared by 156% YoY and by 2.9% from the previous quarter

The stock's price to book (P/B) is 77% less than its 5-year quarterly average of 5.1 and 4.2% less than its last 4 quarters average of 1.2

QDEL's revenue has surged by 92% year-on-year and by 8% since the previous quarter

QDEL's P/S is 68% below its 5-year quarterly average of 4.7 and 12% below its last 4 quarters average of 1.7

How efficient is Quidel business performance

QDEL's return on invested capital has dropped by 82% year-on-year and by 45% since the previous quarter

QDEL's return on assets has dropped by 78% year-on-year and by 47% since the previous quarter

Quidel's return on equity has shrunk by 70% YoY and by 44% QoQ

The company's return on sales has shrunk by 53% YoY and by 32% QoQ

What is QDEL's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for QDEL.

How did Quidel financials performed over time

QDEL's total assets is 126% greater than its total liabilities

QDEL's quick ratio has plunged by 79% YoY

The current ratio has plunged by 65% YoY and by 6% from the previous quarter

QDEL's debt is 43% less than its equity

The equity has soared by 156% YoY and by 2.9% from the previous quarter

The debt to equity has declined by 3.4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.